FibroBiologics (NASDAQ:FBLG) Share Price Dropped 21.1%


FibroBiologics, Inc. (NASDAQ:FBLG – Get a Free Report) fell 21.1% in afternoon trading on Tuesday. The company traded as low as $8.50 and last traded at $9.00. About 221,821 shares changed hands during trading, a 146% increase over the average daily volume of 90,320 shares. The stock previously closed at $11.40.

FibroBiologics is trading 21.1% lower

The stock’s fifty-day moving average is $10.67.

FibroBiologics (NASDAQ:FBLG – Get Free Report) last reported its quarterly earnings results on Tuesday, May 14. The company reported ($0.27) earnings per share (EPS) for the quarter.

About FibroBiologicals

(Get a free report)

FibroBiologics, Inc operates as a cell therapy and regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds more than 150 U.S. and internationally issued patents pending in various clinical pathways, including intervertebral disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversal of organ involution and cancer.

Featured Stories



Receive daily news and reviews for FibroBiologics – Enter your email address below to receive a daily digest of the latest news and analyst ratings for FibroBiologics and related companies with MarketBeat.com’s FREE daily email newsletter.